Log in to save to my catalogue

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4511833

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The p30 isoform of C/EBPα associated with leukemia interacts with WDR5, a component of the SET/MLL histone methyltransferase complex. A small molecule, OICR-9429, disrupted p30-WDR5 interactions, resulting in differentiation of p30-expressing leukemia cells.
The
CEBPA
gene is mutated in 9% of patients with acute myeloid leukemia (AML). Sel...

Alternative Titles

Full title

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4511833

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4511833

Other Identifiers

ISSN

1552-4450

E-ISSN

1552-4469

DOI

10.1038/nchembio.1859

How to access this item